Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Oligodendroglioma 2Neurofibromatosis 1 2Brain Neoplasms 2Rhabdoid Tumor 1Recurrence 1Precancerous Conditions 1Optic Nerve Glioma 1Neurofibroma, Plexiform 1Neoplasms 1Melanoma 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Ependymoma 1Choroid Plexus Neoplasms 1

Interventions

Carboplatin 13Temozolomide 11Filgrastim 9Radiotherapy 6Etoposide 6Vincristine 5Irinotecan 4Granulocyte Colony-Stimulating Factor 4etoposide phosphate 3Peripheral Blood Stem Cell Transplantation 3O(6)-benzylguanine 3Ifosfamide 3Busulfan 3Vorinostat 2Topotecan 2Radiotherapy, Intensity-Modulated 2Psychiatric Rehabilitation 2Oxaliplatin 2Melphalan 2Magnetic Resonance Spectroscopy 2Lenalidomide 2Doxorubicin 2Cyproheptadine 2Cyclophosphamide 2Cilengitide 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2veliparib 1trioctyl phosphine oxide 1tipifarnib 1sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Optic Nerve Glioma × Vinblastine × CNS × Clear all
NCT00352495 2014-02-13

Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

Children's Oncology Group

Phase 1 Completed
26 enrolled
CNS

Astrocytoma, Neurofibromatosis 1, Oligodendroglioma, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡